This is the authors' abstract. We don't add key points for this paper.
While the goal of universal drug susceptibility testing has been a key component of the WHO End TB Strategy, in practice, this remains inaccessible to many. Rapid molecular tests for tuberculosis (TB) and antituberculosis drug resistance could significantly improve access to testing.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Syed et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: